Genomics in acute lymphoblastic leukaemia: insights and treatment implications
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://www.nature.com/articles/nrclinonc.2015.38.pdf
Reference188 articles.
1. Inaba, H., Greaves, M. & Mullighan, C. G. Acute lymphoblastic leukaemia. Lancet 381, 1943–1955 (2013).
2. Ko, R. H. et al. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium Study. J. Clin. Oncol. 28, 648–654 (2010).
3. Raetz, E. A. & Bhatla, T. Where do we stand in the treatment of relapsed acute lymphoblastic leukemia? Hematology Am. Soc. Hematol. Educ. Program 2012, 129–136 (2012).
4. Stock, W. Adolescents and young adults with acute lymphoblastic leukemia. Hematology Am. Soc. Hematol. Educ. Program. 2010, 21–29 (2010).
5. Mullighan, C. G. et al. Rearrangement of CRLF2 in B-progenitor and Down syndrome-associated acute lymphoblastic leukemia. Nat. Genet. 41, 1243–1246 (2009).
Cited by 228 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular pathology and computational profiling of Janus kinase 2 (JAK2) mutation in acute lymphoblastic leukemia: insights from a Pakistani cohort;Laboratory Medicine;2024-08-19
2. Philadelphia chromosome-like acute lymphoblastic leukemia with concomitant rearrangements of CRLF2 and ABL1: a pediatric case report;BMC Pediatrics;2024-08-10
3. Economic Impact of Whole Genome Sequencing and Whole Transcriptome Sequencing Versus Routine Diagnostic Molecular Testing to Stratify Patients with B-Cell Acute Lymphoblastic Leukemia;The Journal of Molecular Diagnostics;2024-08
4. Laboratory validation and clinical utility of next-generation sequencing-based IGH/TCR clonality testing for the monitoring of measurable residual disease in acute lymphoblastic leukaemia: real-world experience at Austin Pathology;Pathology;2024-07
5. Enhancer engagement sustains oncogenic transformation and progression of B-cell precursor acute lymphoblastic leukemia;Journal of Experimental & Clinical Cancer Research;2024-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3